1-156299041-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004319.3(VHLL):c.149C>T(p.Ser50Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000577 in 1,613,136 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004319.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VHLL | NM_001004319.3 | c.149C>T | p.Ser50Leu | missense_variant | 1/1 | ENST00000339922.5 | NP_001004319.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VHLL | ENST00000339922.5 | c.149C>T | p.Ser50Leu | missense_variant | 1/1 | NM_001004319.3 | ENSP00000464258 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152106Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000559 AC: 14AN: 250506Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135526
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1460912Hom.: 0 Cov.: 30 AF XY: 0.0000495 AC XY: 36AN XY: 726830
GnomAD4 genome AF: 0.000197 AC: 30AN: 152224Hom.: 0 Cov.: 30 AF XY: 0.000202 AC XY: 15AN XY: 74408
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2021 | The c.149C>T (p.S50L) alteration is located in exon 1 (coding exon 1) of the VHLL gene. This alteration results from a C to T substitution at nucleotide position 149, causing the serine (S) at amino acid position 50 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at